Search results for: Health Care Systems

Multi-indication Pricing: Pros, Cons and Applicability to the UK

28 October 2015

…with health care system stakeholders was organised to explore (i) the attractiveness of MIP as a potential solution to the challenge of providing optimal pricing for, and reimbursement of, multi-indication…

How to Manage Data Governance in an Era of Real World Evidence (RWE): Working Towards a Set of International Standards

24 November 2015

…that is becoming increasingly widespread in health economics and health services research – with good reason. RWD is information that can be used for health care decision-making which is collected…

A Dose of Economics

…runs through every episode: what can health economics really bring to the most pressing problems in healthcare today?   Topics include:  NICE decision-making and cost-effectiveness thresholds  AI and its role in health…

Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines

5 June 2025

…do not deliver their intended therapeutic benefits for the individuals taking them—due to genetic variations. Despite the tremendous benefits that innovative medicines have brought to patients, health systems, and society,…

Economics of Innovation

…design. Our work encompasses the perspectives of patients, industry, investors, payers, healthcare system decision makers, and policymakers.  We maintain a global outlook, recognising that the health technology industry is international and…

The Dynamics of Drug Shortages

9 January 2024

…include higher out-of-pocket payments for patients as well as more resources being diverted to controlling shortages rather than other healthcare resource utilisation. Recommendations Governments around the world have been working…

R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C

1 July 2018

…related to the performance of the new technology, characteristics of the healthcare system and political factors which can have an effect. Using a multidisciplinary methodological approach combining a theoretical economic…

Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help? A Summary of a Symposium held at HTAi Rome 2017

31 October 2017

…new antibiotics relating to their impact on public health by preventing AMR growth. HTA focuses on health gain to the treated patient. Six types of benefit that are traditionally not included…

OHE at HESG Winter 2018

4 January 2018

A summary of OHE’s activity at the 2018 winter HESG meeting, City, University of London, 10-12th January. OHE team members will play an active role in the forthcoming Health Economists’…